How many patents does
Rigshospitalet have?
patents
297
families
49
granted
48
applications
249
WO
62
US
60
EP
55
CN
17
JP
14
KR
11
RoW
78
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Rigshospitalet
Top ten assignees appearing on patents
2009 - 2018
| thrombologic | 12 |
| curasight | 6 |
| leo pharma | 6 |
| exiqon | 5 |
| holten-andersen, mads | 4 |
| omeros corporation | 3 |
| hemostasis holding | 2 |
| fremont group | 2 |
| nils brunner | 2 |
| scandinavian plastic techology | 2 |
2009
| nils brunner | 2 |
| hemostasis holding | 1 |
| holten-andersen, mads | 1 |
2018
| curasight | 2 |
| omeros corporation | 2 |
| trt innovations | 1 |
| thrombologic | 1 |
Rigshospitalet
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| classification of individuals suffering from cardiovascular diseases according to surviv… 🛈 | 22 | 2008 |
| masp isoforms as inhibitors of complement activation | 20 | 2009 |
| methods of identifying critically ill patients at increased risk of development of organ… 🛈 | 19 | 2008 |
| entrapment of radionuclides in nanoparticle compositions | 14 | 2010 |
| chimeric inhibitor molecules of complement activation | 12 | 2010 |
| ykl-40 as a marker for gastrointestinal cancers | 12 | 2008 |
| systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adre… 🛈 | 11 | 2007 |
| loading technique for preparing radionuclide and ionophore containing liposomes in which… 🛈 | 11 | 2009 |
| compounds capable of modulating/preserving endothelial integrity for use in prevention o… 🛈 | 11 | 2010 |
| 177-lu labeled peptide for site-specific upar-targeting | 10 | 2012 |